Curbstone Financial Management Corp Abbott Laboratories Transaction History

Curbstone Financial Management Corp

$463 Million
Q4 2024

A detailed history of Curbstone Financial Management Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Curbstone Financial Management Corp holds 25,100 shares of ABT stock, worth $3.52 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares

25,100

Previous 24,784 1.28%

Holding current value

$3.52 Million

Previous $2.83 Million 0.5%

% of portfolio

0.61%

Previous 0.62%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	BUY	$111.93 - $119.39 $35,369 - $37,727	316 Added 1.28%	25,100 $2.84 Million
Q3 2024 Oct 03, 2024	SELL	$100.07 - $118.13 $212,348 - $250,671	-2,122 Reduced 7.89%	24,784 $2.83 Million
Q1 2024 Apr 09, 2024	SELL	$109.52 - $120.96 $32,856 - $36,288	-300 Reduced 1.1%	26,906 $3.06 Million
Q4 2023 Jan 08, 2024	BUY	$90.19 - $110.4 $63,133 - $77,280	700 Added 2.64%	27,206 $2.99 Million
Q3 2023 Oct 10, 2023	SELL	$95.53 - $114.62 $28,659 - $34,386	-300 Reduced 1.12%	26,506 $2.57 Million
Q2 2023 Jul 05, 2023	SELL	$100.78 - $112.29 $86,670 - $96,569	-860 Reduced 3.11%	26,806 $2.92 Million
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $54,435 - $64,073	-562 Reduced 1.99%	27,666 $2.8 Million
Q4 2022 Jan 19, 2023	SELL	$95.06 - $111.52 $261,415 - $306,680	-2,750 Reduced 8.88%	28,228 $3.1 Million
Q3 2022 Oct 05, 2022	BUY	$96.76 - $112.03 $774 - $896	8 Added 0.03%	30,978 $3 Million
Q2 2022 Aug 04, 2022	SELL	$102.07 - $123.37 $14,493 - $17,518	-142 Reduced 0.46%	30,970 $3.37 Million
Q1 2022 Apr 18, 2022	SELL	$114.02 - $139.04 $45,608 - $55,616	-400 Reduced 1.27%	31,112 $3.68 Million
Q4 2021 Jan 19, 2022	SELL	$115.53 - $141.46 $55,454 - $67,900	-480 Reduced 1.5%	31,512 $4.44 Million
Q3 2021 Oct 06, 2021	SELL	$116.66 - $129.06 $23,332 - $25,812	-200 Reduced 0.62%	31,992 $3.78 Million
Q2 2021 Jul 09, 2021	SELL	$105.79 - $124.53 $78,707 - $92,650	-744 Reduced 2.26%	32,192 $3.73 Million
Q1 2021 Apr 05, 2021	SELL	$108.84 - $128.23 $201,354 - $237,225	-1,850 Reduced 5.32%	32,936 $3.95 Million
Q4 2020 Jan 14, 2021	SELL	$105.0 - $114.42 $44,520 - $48,514	-424 Reduced 1.2%	34,786 $3.81 Million
Q3 2020 Oct 02, 2020	SELL	$91.64 - $111.29 $114,550 - $139,112	-1,250 Reduced 3.43%	35,210 $3.83 Million
Q2 2020 Jul 10, 2020	SELL	$76.57 - $98.0 $104,594 - $133,868	-1,366 Reduced 3.61%	36,460 $3.33 Million
Q1 2020 Apr 20, 2020	SELL	$62.82 - $91.86 $64,830 - $94,799	-1,032 Reduced 2.66%	37,826 $2.99 Million
Q4 2019 Jan 10, 2020	SELL	$78.51 - $87.4 $13,660 - $15,207	-174 Reduced 0.45%	38,858 $3.38 Million
Q3 2019 Oct 18, 2019	SELL	$81.84 - $88.74 $13,585 - $14,730	-166 Reduced 0.42%	39,032 $3.27 Million
Q2 2019 Jul 09, 2019	SELL	$72.88 - $85.0 $129,799 - $151,385	-1,781 Reduced 4.35%	39,198 $3.3 Million
Q1 2019 Apr 10, 2019	BUY	$66.22 - $80.06 $56,750 - $68,611	857 Added 2.14%	40,979 $3.28 Million
Q4 2018 Jan 09, 2019	SELL	$65.56 - $74.27 $2,622 - $2,970	-40 Reduced 0.1%	40,122 $2.9 Million
Q4 2018 Jan 08, 2019	SELL	$65.56 - $74.27 $7,211 - $8,169	-110 Reduced 0.27%	40,162 $2.45 Million
Q3 2018 Oct 10, 2018	BUY	$60.81 - $73.36 $6,689 - $8,069	110 Added 0.27%	40,272 $2.95 Million
Q2 2018 Jul 06, 2018	SELL	$57.57 - $63.54 $4,145 - $4,574	-72 Reduced 0.18%	40,162 $2.45 Million
Q1 2018 Apr 10, 2018	BUY	$56.27 - $63.62 $1.13 Million - $1.28 Million	20,067 Added 99.5%	40,234 $2.41 Million
Q4 2017 Jan 08, 2018	SELL	$53.68 - $57.47 $1.05 Million - $1.12 Million	-19,561 Reduced 49.24%	20,167 $1.15 Million
Q3 2017 Oct 03, 2017	BUY	$48.06 - $53.64 $1.91 Million - $2.13 Million	39,728	39,728 $2.12 Million

Others Institutions Holding ABT

# of Institutions

3,371

Shares Held

1.36B

Call Options Held

10.6M

Put Options Held

8.73M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $246B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Curbstone Financial Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Curbstone Financial Management Corp with notifications on news.

Account

Curbstone Financial Management Corp Abbott Laboratories Transaction History